Learn / COGT
NASDAQ: COGT
Cogent Biosciences (COGT) stock, explained like you're 5
Cogent Biosciences trades on the Nasdaq under the ticker COGT. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 5.4 billion dollars.
- Ticker
- COGT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 5.4 billion dollars
Is Cogent Biosciences a small, medium or large cap company?
No. Cogent Biosciences is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 5.4 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Cogent Biosciences makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves COGT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Did FDA Filings Just Shift Cogent Biosciences Stock Investment Narrative? (Simply Wall Street)
- Cogent Biosciences (COGT) Stock Trades At A Premium As FDA Accepts NDA (Yahoo Finance)
- Here’s How Much You Would Have Made Owning Cogent Biosciences Stock In The Last 5 Years (Benzinga)
- Technical Reactions to COGT Trends in Macro Strategies (Stock Traders Daily)
- Cogent Biosciences: 3 NDAs Create A Time To Market Moat (NASDAQ:COGT) (Seeking Alpha)
Follow COGT in your daily brief
Each trading day at 5 PM ET we post what happened to Cogent Biosciences and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow COGT
Questions about Cogent Biosciences stock
What does Cogent Biosciences do?
Cogent Biosciences trades on the Nasdaq under the ticker COGT. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 5.4 billion dollars.
What is the ticker symbol for Cogent Biosciences?
Cogent Biosciences trades under the ticker COGT on the Nasdaq.
What is Cogent Biosciences's market cap?
Cogent Biosciences is a mid cap stock with a market cap of about 5.4 billion dollars.
How does Cogent Biosciences make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves COGT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow COGT stock every day?
Add COGT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.